RBC Capital Maintains Outperform on Dollarama, Raises Price Target to C$93

RBC Capital analyst Irene Nattel maintains Dollarama (TSX:DOL) with a Outperform and raises the price target from C$81 to C$93.

byBenzinga Newsdesk

August 31, 2022

1 minute read

RBC Capital analyst Irene Nattel maintains Dollarama (TSX:DOL) with a Outperform and raises the price target from C$81 to C$93.

Semler Announces Clinical Study Published Using QuantaFlo As An Aid For Diagnosis Of Heart Dysfunction In The Primary Care Setting

By Happy Mohamed

Today, 7:21 AM

Semler Scientific, Inc. (NASDAQ:SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers (HCPs), today announced the publication of a study in

SMLR

SEC Says Has Added Mogu Inc, Cheetah Mobile, Alibaba Group Holding, Boqii Holding Limited In Its Conclusive List Of Issuers Identified Under Holding Foreign Companies Accountable Act

By Benzinga Newsdesk

Today, 7:21 AM

-Reuters

BABA

Analyst Ratings

8 Analysts Have This to Say About Jamf Holding

By Benzinga Insights

Today, 7:21 AM

Over the past 3 months, 8 analysts have published their opinion on Jamf Holding (NASDAQ:JAMF) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

JAMF

Oppenheimer Initiates Coverage On Processa Pharmaceuticals with Outperform Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 7:21 AM

Oppenheimer analyst Francois Brisebois initiates coverage on Processa Pharmaceuticals (NASDAQ:PCSA) with a Outperform rating and announces Price Target of $20.

PCSA

RBC Capital Maintains Outperform on Dollarama, Raises Price Target to C$93

Related Posts

Semler Announces Clinical Study Published Using QuantaFlo As An Aid For Diagnosis Of Heart Dysfunction In The Primary Care Setting

SEC Says Has Added Mogu Inc, Cheetah Mobile, Alibaba Group Holding, Boqii Holding Limited In Its Conclusive List Of Issuers Identified Under Holding Foreign Companies Accountable Act

8 Analysts Have This to Say About Jamf Holding

Oppenheimer Initiates Coverage On Processa Pharmaceuticals with Outperform Rating, Announces Price Target of $20